Pliant Therapeutics Inc (PLRX:NASDAQ)

$1.33 0.04 (3.10%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 89

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Pliant Therapeutics Inc (PLRX:NASDAQ) News Sources

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference

Yahoo Finance

Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference

Yahoo Finance UK

Stock Picks From Seeking Alpha's February 2026 New Analysts

Seeking Alpha

PLRX stock
PLRX stock price
PLRX stock price today
PLRX stock prediction
PLRX earnings date
PLRX news
PLRX price
PLRX share
PLRX share price
PLRX shares
PLRX ceo
PLRX premarket
$PLRX
PLRX ticker
PLRX after hours
PLRX stock
PLRX stock price
PLRX stock price today
PLRX stock prediction
PLRX earnings date
PLRX news
PLRX price
PLRX share
PLRX share price
PLRX shares
PLRX ceo
PLRX premarket
$PLRX
PLRX ticker
PLRX after hours

Pliant Therapeutics Inc (PLRX:NASDAQ) FAQs

toggle

What is the current price of Pliant Therapeutics Inc (PLRX:NASDAQ)?

The current price of Pliant Therapeutics Inc (PLRX:NASDAQ) is $1.33.


toggle

Pliant Therapeutics Inc (PLRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Pliant Therapeutics Inc (PLRX:NASDAQ) since the previous trading day is $0.04.


toggle

Pliant Therapeutics Inc (PLRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Pliant Therapeutics Inc (PLRX:NASDAQ) since the previous trading day is 3.10%.


toggle

What is This Week's average sentiment score for Pliant Therapeutics Inc (PLRX:NASDAQ)?

This Week's average sentiment score for Pliant Therapeutics Inc (PLRX:NASDAQ) is 89 out of 100.


toggle

What is This Week's average sentiment for Pliant Therapeutics Inc (PLRX:NASDAQ)?

This Week's sentiment for Pliant Therapeutics Inc (PLRX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.